Mesenchymal stem cells (MSCs) may be of value in regeneration of renal tissue after
damage; however, lack of biological knowledge and variability of results in animal models …

Bone marrow–derived cells contribute to glomerular cell turnover and repair, but the cell
types involved are unknown. Whether rat mesenchymal stem cells (MSC) can accelerate …

Given its complexity, high metabolic activity and excretory functions, the kidney is particularly
susceptible to acute ischemic and toxin-mediated injury. Current therapies do not facilitate …

Acute kidney injury (AKI) is a rapid loss of renal function. It has high mortality rates. Still,
renal replacement therapy is considered the best solution for recovering AKI. This opens a …

Ischemic nephropathy consists of progressive renal function loss due to renal hypoxia,
inflammation, microvascular rarefaction, and fibrosis. We provide a literature review focused …

Significant progress has been made to advance stem cell products as potential therapies for
kidney diseases: various kinds of stem cells can restore renal function in preclinical models …

Acute renal failure (ARF) is a common disease with high morbidity and mortality. Recovery
from ARF is dependent on the replacement of necrotic tubular cells with functional tubular …

Objective: To systematically evaluate the efficacy of mesenchymal stem cells (MSCs) for
acute kidney injury (AKI) in preclinical studies and to explore the optimal transplantation …

Abstract Background/Aims: Renal tubular cells are the main target of ischemic insult
associated with acute renal injury. Low oxygen and nutrient supplies result in ATP depletion …

Acute kidney injury (AKI) is a frequent clinical disease with a high morbidity rate and
mortality rate, while the treatment options for this intractable disease are limited currently. In …